Concomitant Pulmonary Aspergillosis Following Severe COVID-19

This case report discusses an atypical complication of COVID-19 pneumonia in a 68-year-old male patient, distinguished by the development of cavitary lung disease and a subsequent incidence of invasive pulmonary aspergillosis (IPA). This adverse development transpired following a prolonged hospitali...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2023-06, Vol.15 (6), p.e41112
Main Authors: Munir, Ahmad, Dahhan, Hadi, Huda, Zoha, Lone, Nazir A
Format: Article
Language:English
Subjects:
Aspergillosis
Bacterial infections
COVID-19
Dyspnea
Fungal infections
Hemoptysis
Infectious Disease
Lung diseases
Oxygen saturation
Pneumonia
Pulmonology
Radiology
Respiratory failure
Severe acute respiratory syndrome coronavirus 2
Staphylococcus infections
Steroids
Tomography
Ventilators
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This case report discusses an atypical complication of COVID-19 pneumonia in a 68-year-old male patient, distinguished by the development of cavitary lung disease and a subsequent incidence of invasive pulmonary aspergillosis (IPA). This adverse development transpired following a prolonged hospitalization and an extensive course of corticosteroid therapy post-COVID-19 pneumonia. This case accentuates the importance of vigilance in observing patients with severe COVID-19 pneumonia for potential opportunistic infections, particularly given the inherent risks associated with prolonged corticosteroid therapy. Prompt diagnosis and initiation of treatment are key to enhancing patient outcomes in such presentations.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.41112